Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Maria Jose Galvez Medina (Madrid, Spain), M.J. Galvez, A. Ramos, A. Delgado-Iribarren, J. Solano, B. Steen. Invasive pneumococcal disease (IPN) and pneumococcal vaccination in our setting. Eur Respir J 2015; 46: Suppl. 59, 1853

Member's Comments

No comment yet.

Related content which might interest you: Evolutionary trend of invasive pneumococcal disease according to serotypes Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013) Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012 Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma Year: 2013 Immunity to pneumococcal disease Source: Annual Congress 2013 –New understanding of pneumococcal vaccination Year: 2013 Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Impact of the vaccination campaign on pneumococcal pneumonia after the great East Japan earthquake Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Influenza and pneumococcal vaccination Source: International Congress 2017 – State of the art session: "Respiratory infections" Year: 2017 Pneumococcal vaccination Source: Eur Respir J 2005; 26: 982-983 Year: 2005 Pneumococcal and influenza vaccination Source: Eur Respir Monogr 2014; 63: 266-284 Year: 2014 No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden Source: Eur Respir J 2016; 47: 1208-1218 Year: 2016 Influenza and pneumococcal vaccination in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Impact of nasopharyngeal pneumococcal colonization on dendritic cell-dependent protective immunity against invasive pneumococcal disease in mice Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Pneumococcal carriage and serotypes distribution in patients with acute otitis media in Switzerland, 2004-2014 Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016 Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Pneumococcal and influenza vaccination Source: Respipedia Article Year: 2018